A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.
Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.
Apple is compelling health marketers to adopt privacy-safe, AI-generated digital audiences created from offline RWD instead of online clickstream data.
Swoop spoke with Suda Shinya, Senior Vice President of Information Systems for Astellas Pharma on how to proactively meet the needs of a digital-first patient.
Physicians are now more interested in doing business virtually, whether that means engaging via telehealth or meeting with reps through online channels.
Building relationships with key opinion leaders and working with the most likely brand advocates is critical to achieving optimal patient outcomes and realizing commercial success.